Search Tag: ESC Congress 2024
2024 02 Sep
A study presented at the ESC Congress reveals that performing additional catheter ablations targeting diseased myocardium, alongside the standard pulmonary vein isolation (PVI) approach, does not enhance freedom from arrhythmias at one year for patients with persistent atrial fibrillation (AF). However, a subgroup of patients with left atrium...Read more
2024 01 Sep
Adherence to atrial fibrillation (AF) guideline recommendations in clinical practice across Europe was found to be poor, but a structured educational programme for healthcare professionals significantly improved the implementation of heart rhythm control recommendations, according to research presented in a Hot Line session at the ESC Congress...Read more
2024 31 Aug
Late-breaking research presented at ESC Congress 2024 revealed no significant difference in efficacy between transcatheter edge-to-edge repair (TEER) and surgery for patients with secondary mitral regurgitation (MR). TEER is a common treatment for secondary MR, but until now, no randomised trial has compared it with surgery. The MATTERHORN...Read more
2024 30 Aug
Vutrisiran significantly reduced mortality, cardiovascular events, and markers of disease progression in patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM), according to late-breaking research presented today in a Hot Line session at ESC Congress 2024. ATTR is a progressive, fatal disease characterised by the accumulation...Read more